| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/21/2003 | US20030158091 Increasing function of organs having reduced red blood cell flow |
| 08/21/2003 | US20030158085 For diagnosis and therapy of pancreatic disorders, particularly type I diabetes |
| 08/21/2003 | US20030157712 Initiating, promoting and/or directing cell attachment to a matrix or to another cell comprising tyrosine kinase receptors/ephrin-b1 (EPHB) for inhibiting leukocyte/platelet migration/attachment; neovascularization |
| 08/21/2003 | US20030157711 STAT3 activated stem cell |
| 08/21/2003 | US20030157708 Cell stimulation apparatus and a cell stimulation method |
| 08/21/2003 | US20030157705 Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system |
| 08/21/2003 | US20030157704 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors |
| 08/21/2003 | US20030157703 Recombinant herpesvirus of turkeys and use thereof |
| 08/21/2003 | US20030157693 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 08/21/2003 | US20030157690 Fusion protein delivery system and uses thereof |
| 08/21/2003 | US20030157689 Plasmid capable of-directly transfecting cell and expressing nidovirales virus; gene therapy; veterinary medicine; genetic vaccines; immunotherapy |
| 08/21/2003 | US20030157688 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 08/21/2003 | US20030157687 Comprises nucleotide sequences coding enzyme inhibitor (TIMP-4) for treatment of arthritis, cancer and scarring |
| 08/21/2003 | US20030157686 Comprises polypeptide which affects blood coagulation and platelet aggregation for treatment of blood/hemostatic disorders |
| 08/21/2003 | US20030157685 Comprises nucleotide sequences coding retinoblastoma-interacting myosin-like gene (RIM), serine protease (OMI) and oncogene protein (NMI) for use as anticarcinogenic/antiproliferative agents |
| 08/21/2003 | US20030157683 Antibodies for apoptosis EI24 protein and methods of use |
| 08/21/2003 | US20030157682 Preparing preferential amino acid sequences in vitro; detecting restriction fragment length polymorphisms |
| 08/21/2003 | US20030157667 Method for producing L-amino acids using bacteria belonging to the genus escherichia |
| 08/21/2003 | US20030157662 Compositions and methods for recombinational cloning of nucleic acid molecules |
| 08/21/2003 | US20030157660 Non-M, non-O HIV-1 strains, fragments and uses |
| 08/21/2003 | US20030157659 Proteins isolated from cyanobacteria |
| 08/21/2003 | US20030157651 Isolated GAGE-7B and 8 proteins |
| 08/21/2003 | US20030157650 Recombinant P. vivax merozoite protein-1 p42 vaccine |
| 08/21/2003 | US20030157649 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/21/2003 | US20030157648 Membrane binding polypeptides derived from urogenital and placenta tissue for monitoring and detecting modulators of ligand bind activity; drug screening |
| 08/21/2003 | US20030157647 Comprises calcium/glutamate receptor chimera comprising extracellular domain of G-protein coupled membrane protein for treating nervous system disorders |
| 08/21/2003 | US20030157644 Comprises amino acid sequences fused to polyclonal/monoclonal antibody for detecting modulators and monitoring G-protein binding activity; high throughput assays |
| 08/21/2003 | US20030157643 Synthetic nucleic acids from aquatic species |
| 08/21/2003 | US20030157642 Bacillus genetically engineeered for improved expression of secretion factor G (SECG) and heterologous proteins |
| 08/21/2003 | US20030157639 Comprises genetically engineered eotaxin mediated cytokine receptor (CCR3) with reduced internalized and/or kinase mediated phosphorylation; antiinflammatory agents |
| 08/21/2003 | US20030157638 Comprises microbiocidal protein for treating ear and vision defects; contraceptives |
| 08/21/2003 | US20030157635 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157633 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders |
| 08/21/2003 | US20030157632 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157631 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157630 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157629 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157628 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157627 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157626 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157625 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157624 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157623 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157621 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157620 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157619 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157618 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157617 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157616 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157615 Comprises chimeric membrane protein for diagnosis and treatment of autoimmune, cancer and inflammatory disorders |
| 08/21/2003 | US20030157614 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157613 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157612 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157611 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157610 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157609 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157608 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157607 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157606 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157605 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157604 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157603 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157602 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/21/2003 | US20030157601 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 08/21/2003 | US20030157600 Comprises human cardiac sodium channel alpha polypeptide (SCN5A) for diagnosis and prevention arrhythmias; restriction fragment length polymorphisms; bradycardial agents |
| 08/21/2003 | US20030157599 Comprises nucleotide sequence coding prostaglandin E receptor (EP3) for diagnosis and treatment of atherosclerotic diseases; restriction fragment length polymorphisms |
| 08/21/2003 | US20030157598 Membrane protein associated with nuclear factor activated t-cells for diagnosing and treating cell proliferative/kidney disorders |
| 08/21/2003 | US20030157595 Fungal culture for generating neutral or alkaline glucanases for biopolishing, defribillating, bleaching, dyeing, or desizing textiles; laundry detergents |
| 08/21/2003 | US20030157578 Providing a yeast cell containing an aequorin-encoding deoxyribonucleic acid sequence expressibly linked to a consituttive yeast promoter, incubating the yeast cell, measuring the amount of aequorin produced |
| 08/21/2003 | US20030157577 Using myeloid cells which are expressing IAP (Integrin Associated Protein) and screening the substances (antibodies) having property of causing apoptosis |
| 08/21/2003 | US20030157576 Epithelial cell growth inhibitors |
| 08/21/2003 | US20030157571 A nucleic acid encoding a modified olfactory cyclic nucleotide-gated ion channel, and the channel contains mutations which together impart increased cyclic AMP sensitivity and decreased cyclic GMP sensitivity |
| 08/21/2003 | US20030157569 Novel genes associated with the maintenance of differentiation of smooth muscle cells |
| 08/21/2003 | US20030157568 SF, a novel family of taste receptors |
| 08/21/2003 | US20030157567 In a polypeptide containing 11 amino acids and lysine 5 being conjugated with malonaldehyde (MDA), inhibits uptake by the high affinity low density lipoprotein (LDL) receptor of LDL or a partially modified form |
| 08/21/2003 | US20030157562 Protein is characterized in that it elicits an immunological response from a mammal; has been prepared by expression in a bacterium other than Borrelia burgdorferi; free of other Borrelia proteins and has specific amino acid sequence |
| 08/21/2003 | US20030157561 Combinatorial libraries of monomer domains |
| 08/21/2003 | US20030157560 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 08/21/2003 | US20030157558 Nine novel genes containing nucleotide sequences encoding hydrophobic regions considered to be seven transmembrane domains, which are cherateristic of the G-protein-coupled receptors, by PCR using cDNAs from human tissues as templates |
| 08/21/2003 | US20030157554 Purified complex of a first and second polypeptide, where at least one of the polypeptides is an insulin-signaling, vesicular-trafficking, calcium binding protein; complexing segments of first and second polypeptides; decomplexing |
| 08/21/2003 | US20030157541 Central nervous system disorders; cardiovascular disorders;antiasthma agents |
| 08/21/2003 | US20030157525 Novel human G-protein coupled receptor, HGPRBMY31, and variants and methods of use thereof |
| 08/21/2003 | US20030157521 Binding to monoclonal or polyclonal antibodies; anticancer, antitumor agents |
| 08/21/2003 | US20030157519 Energy transfer between chromogens; gene expression cassette; medical diagnosis |
| 08/21/2003 | US20030157516 Medical diagnosis; binding with adenine |
| 08/21/2003 | US20030157514 Therapy for immunology disorders; kinase inhibitors; anticancer agents |
| 08/21/2003 | US20030157512 Transmembrane protein; diagnosis of central nervous system disorders |
| 08/21/2003 | US20030157511 Polynucleotides; receptor for melamin concentrating hormone |
| 08/21/2003 | US20030157508 Genetic engineering; gene therapy |
| 08/21/2003 | US20030157506 Interferon-alpha induced genes |
| 08/21/2003 | US20030157500 Pyrrolidinyl peptide nucleic acids |
| 08/21/2003 | US20030157495 Hybrid Dna sequence; amplification, polymerase chain reactions |
| 08/21/2003 | US20030157494 Smooth muscle cell promoter and uses thereof |
| 08/21/2003 | US20030157491 HarA polypeptides and nucleic acids, and related methods and uses thereof |
| 08/21/2003 | US20030157487 Nucleic acid ligands |
| 08/21/2003 | US20030157485 Forensic analysis; chromosome marking |
| 08/21/2003 | US20030157479 Antigen arrays for treatment of allergic eosinophilic diseases |
| 08/21/2003 | US20030157160 Vaccine for modulating between T1 and T2 immune responses |
| 08/21/2003 | US20030157135 Enhancement and/or extension of antigen-specific Th1-type responses, in particular, CD8+ T cell responses; for treatment of various infectious and neoplastic diseases |